scispace - formally typeset
Z

Zhe Wang

Researcher at University of Oxford

Publications -  20
Citations -  2878

Zhe Wang is an academic researcher from University of Oxford. The author has contributed to research in topics: Breast cancer & Radiation therapy. The author has an hindex of 8, co-authored 14 publications receiving 2068 citations.

Papers
More filters
Journal ArticleDOI

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

TL;DR: After mastectomy and axillary dissection, radiotherapy reduced both recurrence and breast cancer mortality in the women with one to three positive lymph nodes in these trials even when systemic therapy was given.
Journal ArticleDOI

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Bernard Asselain, +109 more
- 01 Jan 2018 - 
TL;DR: Tumours downsized by NACT might have higher local recurrence after breast-conserving therapy than might tumours of the same dimensions in women who have not received NACT.
Journal ArticleDOI

Exposure of the Heart in Breast Cancer Radiation Therapy: A Systematic Review of Heart Doses Published During 2003 to 2013

TL;DR: A systematic review of heart doses from breast cancer radiation therapy that were published during 2003 to 2013 finds recent estimates of typical heart doses vary widely between studies, even for apparently similar regimens.
Journal ArticleDOI

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

Richard Gray, +165 more
- 06 Apr 2019 - 
TL;DR: Increasing the dose intensity of adjuvant chemotherapy by shortening the interval between treatment cycles, or by giving individual drugs sequentially rather than giving the same drugs concurrently, moderately reduces the 10-year risk of recurrence and death from breast cancer without increasing mortality from other causes.
Journal ArticleDOI

Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010-2015.

TL;DR: Lymph node inclusion and IMRT use increased exposure, while breathing adaptation and prone/lateral decubitus positioning reduced it, while lung doses from breast cancer radiotherapy varied substantially worldwide.